Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Mounjaro
Pharma
Lilly cuts revenue guidance as momentum stalls for tirzepatide
Sales of Eli Lilly’s tirzepatide products fell far short of expectations in Q3, leading the juggernaut company to reduce its annual revenue guidance.
Kevin Dunleavy
Oct 30, 2024 9:47am
UK warns GLP-1s not for 'body beautiful picture for Instagram'
Oct 25, 2024 8:20am
Novo asks FDA to prevent compounders from making GLP-1 knockoffs
Oct 23, 2024 2:29pm
FDA reviews decision to put Lilly's tirzepatide on shortage list
Oct 14, 2024 11:20am
In China, Lilly plans $200M expansion to make tirzepatide meds
Oct 11, 2024 11:00am
Minus one of its GLP-1 cash cows, compounding group sues FDA
Oct 8, 2024 10:52am